15 Participants Needed

SHAREDCare Plan for Lung Cancer Survivors

(SHAREDCare Trial)

SB
Overseen BySarah Birken, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Wake Forest University Health Sciences
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how a shared response plan called SHAREDCare can improve follow-up care for lung cancer survivors. The goal is to ensure survivors receive necessary support by collaborating with a navigator to address concerns and set personal goals. This plan seeks to enhance the quality of care by anticipating challenges and adjusting support as needed. Suitable candidates for this trial include individuals diagnosed with lung cancer within the past two years who can communicate in English. As an unphased trial, participants can contribute to innovative care strategies that may enhance support for future lung cancer survivors.

Do I have to stop taking my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on improving follow-up care rather than changing medication regimens.

What prior data suggests that the SHAREDCare plan is safe for lung cancer survivors?

Research shows that SHAREDCare, which involves working closely with a guide to meet patient needs, is generally well-liked. Studies of similar shared care methods often show better patient outcomes without major safety issues. No specific evidence indicates harmful effects from using SHAREDCare itself. Since this trial focuses on improving follow-up care rather than introducing a new drug or procedure, safety concerns remain minimal. Participants can feel reassured that the focus is on supportive care and communication, which have been shown to improve patient well-being.12345

Why are researchers excited about this trial?

Researchers are excited about the SHAREDCare plan for lung cancer survivors because it focuses on personalized supportive care. Unlike standard treatments that primarily address the physical aspects of lung cancer, SHAREDCare targets the emotional and social challenges survivors face. This approach involves one-on-one calls with a navigator to create a tailored response plan for each patient's unique distress and social needs. By integrating supportive care with standard referrals, SHAREDCare aims to enhance overall well-being and quality of life for lung cancer survivors.

What evidence suggests that the SHAREDCare plan is effective for improving follow-up care for lung cancer survivors?

Research has shown that shared care models, such as SHAREDCare, which participants in this trial will receive, can maintain the quality of life for cancer patients as effectively as traditional oncologist-led care. Studies have found that patients in shared care programs often feel as satisfied as those receiving direct specialist care. For lung cancer patients, programs that include support like coping skills and education have improved depression, quality of life, and confidence in managing their own care. Additionally, these programs can reduce costs for cancer survivors, making care more accessible. Overall, SHAREDCare aims to meet patient needs effectively by involving them in their care plan, potentially improving their follow-up care experiences.678910

Are You a Good Fit for This Trial?

This trial is for lung cancer survivors who need help with follow-up care. Participants will work with a navigator to address their distress and social needs, set goals, and overcome barriers. There's no specific exclusion criteria provided.

Inclusion Criteria

Ability to understand and the willingness to sign an institutional review board (IRB)-approved informed consent document
Able to understand, read and write English
I was diagnosed with lung cancer less than two years ago.
See 1 more

Exclusion Criteria

Does not meet the above inclusion criteria

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive a SHAREDCare call with a navigator to discuss identified distress and social needs and develop a shared response plan. Two weeks following the initial call, patients receive a second SHAREDCare call to follow-up on the shared response plan.

2 weeks
2 calls (virtual)

Follow-up

Participants are monitored for safety and effectiveness after the intervention, including assessment of SHAREDCare's acceptability, feasibility, and appropriateness.

4 weeks
1 follow-up call (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • SHAREDCare
Trial Overview The trial tests SHAREDCare, which includes telephone interviews, electronic health record reviews, referrals, and surveys via questionnaires to improve chronic illness care among lung cancer survivors.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: SHAREDCare Supportive care armExperimental Treatment4 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Published Research Related to This Trial

A systematic review of 11 studies, including 8 randomized controlled trials, found that the shared care model for cancer survivors is as effective as usual care in terms of quality of life and clinical outcomes, while also being highly acceptable to patients and practitioners.
Patient satisfaction with shared care was reported to be higher than with usual care, suggesting that improved communication between primary and hospital care can enhance follow-up for cancer survivors.
The Effectiveness of Shared Care in Cancer Survivors-A Systematic Review.Zhao, Y., Brettle, A., Qiu, L.[2022]
Patients with lung cancer often experience significant physical and psychological distress, which can greatly reduce their quality of life, highlighting the need for effective survivorship care.
A multidisciplinary approach to survivorship care is essential for addressing the long-term effects of lung cancer treatment, and further research is needed to develop evidence-based practices that can improve patient outcomes.
Survivorship issues for patients with lung cancer.Pozo, CL., Morgan, MA., Gray, JE.[2022]
In a study of 66 patients with operable stage III non-small cell lung cancer (NSCLC), the combination of Camrelizumab with Docetaxel and Cisplatin showed good overall safety, with most adverse events (AEs) being mild (grade 1-2) and only 9.1% being severe (grade 3-4).
The supervision of adverse events during neoadjuvant therapy not only helped in managing complications but also led to an improvement in patients' quality of life, indicating that careful monitoring can enhance treatment outcomes.
[Role of Adverse Events Supervision in Clinical Trials in Neoadjuvant Treatment of Operable Stage III NSCLC].Zhang, Y., Zhou, S., Tao, W., et al.[2023]

Citations

Effectiveness and implementation of models of cancer ...Costs to individual cancer survivors were reported to be lower with primary care provider-led models of care compared to specialist-led care, ...
Shared Care Is an Appropriate Model for Many Cancer ...Both studies showed similar quality-of-life outcomes for patients assigned either to shared care or to usual oncologist-led care. Both showed ...
Lung Cancer Patients' and Caregivers' Satisfaction With ...We compared lung cancer patients' and caregivers' satisfaction with Multidisciplinary Care to routine, serial care.
Supportive Oncology in Lung CancerIn coping skills training and group education programs, patients show improved depression, quality of life, and self-efficacy, while care partners show lower ...
Baseline characteristics of survivors, primary care ...At baseline, survivors reported moderate overall scores for their experiences with cancer care, particularly in receiving timely appointments ...
Associations between Shared Care and Patient ...Results: Among 10,132 survivors, 15% received Shared Care; 10% Oncologist-led; 33% PCP-led; and 42% Other. Compared with Shared Care, we found ...
Characteristics of patients with lung cancer at a large safety ...Conclusions: The lung cancer patient population at our safety net system is significantly different from the national average. Notably, 10% of ...
Unanswered Questions in Lung Cancer Survivorship CareOutcomes included self-reported physical function; objective physical function, exercise capacity, and strength; and multiple patient-reported ...
Identifying and exploring patient engagement interventions ...National Outcome Programme analysis shows an increase in the volume of activity and a decrease in 30-day mortality after integrated care pathway implementation.
Lung Cancer Screening Uptake and Psychological OutcomesLung cancer screening (LCS) programs face complex challenges about how to facilitate uptake while minimizing potential harms, including participant regret and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security